Lotus Eye Hospital Complete Financial Statements

In FYNone, Lotus Eye Hospital (LOTUSEYE) reported revenue ₹53 Cr, net profit ₹1 Cr and EPS ₹0.30, with a net profit margin of 2.0% and ROE of 1.7%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see LOTUSEYE stock live price.

11 Years of Data
2025 - 2015

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 1.96% 2025 data
EBITDA Margin 9.80% 2025 data
Operating Margin 7.00% 2025 data
Return on Assets 1.43% 2025 data
Return on Equity 1.67% 2025 data

Balance Sheet Ratios

Current Ratio 6.00 2025 data
Equity Ratio 85.71% 2025 data
Asset Turnover 0.73 2025 data

LOTUSEYE Revenue, Net Profit & EBITDA — Year-on-Year Growth

LOTUSEYE YoY (March 2025 vs Period) — revenue +3.9%, EBITDA -20.0%, expenses +6.5%.

Revenue Growth
+3.9%
Year-over-Year
EBITDA Growth
-20.0%
Year-over-Year
Expense Growth
+6.5%
Year-over-Year
Assets Growth
+4.5%
Year-over-Year
Equity Growth
+1.7%
Year-over-Year
Operating Cash Flow Growth
-50.0%
Year-over-Year
Investing Cash Flow Growth
-20.0%
Year-over-Year
Financing Cash Flow Growth
+33.3%
Year-over-Year

LOTUSEYE Income Statement — Revenue, EBITDA & Net Profit

Lotus Eye Hospital revenue ₹53 Cr, EBITDA ₹4 Cr, net profit ₹1 Cr, EPS ₹0.30 (None) — net profit margin 2.0%. Explore Lotus Eye Hospital intrinsic price to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 53 51 50 48 40 33 42 39 39 35 32 30
Expenses 49 46 42 40 33 29 37 35 34 31 27 28
EBITDA 4 5 8 9 7 4 5 4 5 4 5 3
Operating Profit Margin % 5.00% 7.00% 14.00% 16.00% 15.00% 11.00% 9.00% 8.00% 11.00% 10.00% 13.00% 7.00%
Depreciation 2 3 4 3 3 2 3 3 3 3 4 5
Interest 1 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 4 6 4 2 2 1 2 0 0 -2
Tax 0 1 1 2 1 0 0 0 0 0 0 0
Net Profit 1 1 3 4 3 2 1 1 2 0 0 -2
Earnings Per Share (₹) 0.30 0.36 1.40 1.96 1.44 0.75 0.51 0.34 0.84 0.21 0.05 -0.95

LOTUSEYE Balance Sheet — Assets, Liabilities & Shareholders' Equity

LOTUSEYE total assets ₹70 Cr, total equity ₹60 Cr, total liabilities ₹ Cr (2025) — ROE 1.7%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 70 67 63 62 59 58 57 58 55 55 56
Current Assets 12 14 15 13 14 11 7 8 7 6 5
Fixed Assets 54 49 44 44 41 43 44 43 41 44 47
Capital Work in Progress 0 0 0 0 0 0 0 0 1 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets 16 18 19 18 19 15 12 15 13 11 9
LIABILITIES
Total Liabilities
Current Liabilities 2 1 0 1 1 1 1 1 1 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 60 59 58 55 53 51 50 51 50 50 49
Share Capital 21 21 21 21 21 21 21 21 21 21 21
Reserves & Surplus 39 39 37 34 32 31 29 30 29 29 29

LOTUSEYE Cash Flow Statement — Operating, Investing & Financing

Lotus Eye Hospital operating cash flow ₹3 Cr, investing ₹-6 Cr, financing ₹-2 Cr, net cash flow ₹-5 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 3 6 4 4 3 5 4 6 3 3 2
Investing Activities -6 -5 -2 -4 1 -1 -4 -4 -1 -1 -5
Financing Activities -2 -3 -2 -2 0 0 -1 -2 0 -1 2
Net Cash Flow -5 -2 1 -1 3 4 -1 0 2 2 0